Antibodies having a mutated amino acid residue at position 268 (CH2 region) in constant regions

Details for Australian Patent Application No. 2004283135 (hide)

Owner Cambridge University Technical Services Limited

Inventors Clark, Michael Ronald; Armour, Kathryn Lesley

Agent Griffith Hack

Pub. Number AU-B-2004283135

PCT Pub. Number WO2005/040217

Priority 0324368.0 17.10.03 GB

Filing date 7 October 2004

Wipo publication date 6 May 2005

Acceptance publication date 14 August 2008

International Classifications

C07K 16/34 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

4 May 2006 PCT application entered the National Phase

  PCT publication WO2005/040217 Priority application(s): WO2005/040217

14 August 2008 Application Accepted

  Published as AU-B-2004283135

11 December 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004283137-4-(pyrazol-3-ylamino) pyrimidine derivatives for use in the treatment of cancer

2004283133-Mirror glass component comprising an integrated luminous film